Yoichi Furukawa

Molecular Biology · 2000–2017

A researcher in the Science corpus: 11 papers; trusts 4 researchers and is trusted by 7 researchers here, as inferred from the citation graph.

Subfields

• Molecular Biology — 63 citations into it; #4,393 of 17,773 by trust here, #3,004 by citations

Whom Yoichi Furukawa trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. Ryuji Hamamoto

Who trusts Yoichi Furukawa overall

1. Ryuji Hamamoto
2. Lianhua Piao
3. Takehiro Suzuki
4. Hyun-soo Cho
5. Makoto Nakakido
6. G. Toyokawa
7. Zhenzhong Deng
8. S. Hayami
9. Yusuke Nakamura
10. N. Dohmae

Papers from Yoichi Furukawa's perspective

Ordered by how strongly the researchers Yoichi Furukawa trusts endorse each paper. Same corpus, a different order for every researcher.

1. Regulation of chromatin structure by site-specific histone H3 methyltransferases (Nature)
2. Active genes are tri-methylated at K4 of histone H3 (Nature)
3. Histone methylation in transcriptional control. (Current Opinion in Genetics and Development)
4. The language of covalent histone modifications (Nature)
5. Targeted recruitment of Set1 histone methylase by elongating Pol II provides a localized mark and memory of recent transcriptional activity. (Molecules and Cells)
6. ALL-1 is a histone methyltransferase that assembles a supercomplex of proteins involved in transcriptional regulation. (Molecules and Cells)
7. Role of Histone H3 Lysine 27 Methylation in Polycomb-Group Silencing (Science)
8. Correlation Between Histone Lysine Methylation and Developmental Changes at the Chicken β-Globin Locus (Science)
9. MLL targets SET domain methyltransferase activity to Hox gene promoters. (Molecules and Cells)
10. SET Domain-containing Protein, G9a, Is a Novel Lysine-preferring Mammalian Histone Methyltransferase with Hyperactivity and Specific Selectivity to Lysines 9 and 27 of Histone H3* (Journal of Biological Chemistry)

Their papers

• SMYD3 encodes a histone methyltransferase involved in the proliferation of cancer cells (2004) — 748 citations
• Enhanced SMYD3 expression is essential for the growth of breast cancer cells (2006) — 265 citations
• AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1 (2000) — 1,002 citations
• A variable number of tandem repeats polymorphism in an E2F-1 binding element in the 5′ flanking region of SMYD3 is a risk factor for human cancers (2005) — 127 citations
• The lysine 831 of vascular endothelial growth factor receptor 1 is a novel target of methylation by SMYD3. (2007) — 149 citations
• Enhanced methyltransferase activity of SMYD3 by the cleavage of its N-terminal region in human cancer cells (2008) — 59 citations
• Overview of the BioBank Japan Project: Study design and profile (2017) — 649 citations
• Late Cornified Envelope Group I, a Novel Target of p53, Regulates PRMT5 Activity (2014) — 25 citations
• Enhanced Expression of RAD51 Associating Protein-1 Is Involved in the Growth of Intrahepatic Cholangiocarcinoma Cells (2008) — 52 citations
• Isolation of a novel human gene, APCDD1, as a direct target of the beta-Catenin/T-cell factor 4 complex with probable involvement in colorectal carcinogenesis. (2002) — 100 citations
• Isolation and characterization of a novel human gene, VANGL1, as a therapeutic target for hepatocellular carcinoma. (2002) — 35 citations